Managing covid-19 with ivermectin in Zimbabwe
Interview and article by Christine Clark. Dr Jackie Stone describes how large doses of ivermectin are safe and effective for the treatment of covid-19 and side effects are… read more.
Interview and article by Christine Clark. Dr Jackie Stone describes how large doses of ivermectin are safe and effective for the treatment of covid-19 and side effects are… read more.
Oncopeptides AB announced that the Company has submitted an application to the European Medicines Agency, EMA, for conditional marketing authorization of melflufen (melphalan flufenamide) in the EU, based… read more.
Article written by Bruce Sylvester. E-cigarettes delivering cigarette-like levels of nicotine can reduce smoking and exposure to the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, also known as NNAL.
Interview and article by Christine Clark. Dr Jackie Stone, who has treated numerous covid-19 patients, explains how ivermectin is used in early stage disease to prevent progression and… read more.
A hypothesis has been put forward as to why COVID-19 Vaccine AstraZeneca (ChAdOx1 nCov-19) seems to trigger an abnormal and potentially life-threatening combination of blood clotting and low… read more.
Article by Bruce Sylvester A CAR (chimeric antigen receptor) T-cell therapy (idecabtagene vicleucel) more than triples the expected length of remission for multiple myeloma patients who have relapsed… read more.
The use of ivermectin for prophylaxis and treatment of covid-19 in Zimbabwe has resulted in a 10-fold reduction in mortality. IMI interviewed Dr Jackie Stone, a family medicine physician in based in Harare, Zimbabwe to find out more.
Gilead Sciences, Inc. announced that the FDA has granted full approval to Trodelvy (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC)… read more.
Cycling at moderate intensity during dialysis could drastically improve the heart health of patients with kidney failure and result in significant savings for the NHS, according to new… read more.
FibroGen, Inc. has provided clarification of certain prior disclosures of U.S. primary cardiovascular safety analyses from the roxadustat Phase III program for the treatment of anemia of chronic… read more.
Merck Inc., announced that the FDA has issued a Complete Response Letter (CRL) regarding Merck’s supplemental Biologics License Application (sBLA) seeking approval for Keytruda, the company’s anti-PD-1 therapy,… read more.
Exercise and a healthy diet in childhood leads to adults with bigger brains and lower levels of anxiety, according to new UC Riverside research in mice.